Senior Trade Operations Specialist at Gilead Sciences

Uxbridge, England, United Kingdom

Gilead Sciences Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

  • Experience managing commercial supply chains in collaboration with commercial leads and distributors
  • Ability to minimize forecast volatility and forecast variance
  • Expertise in new product introduction (NPI) and on-boarding new distribution partners
  • Skills in system setup for new client ship-to locations
  • Knowledge of quality evaluation of Purchase Orders in compliance with Distribution Agreements
  • Proficiency in system price maintenance
  • Capability to manage rolling commercial forecasts with distributors and Commercial Leads
  • Experience collaborating with key stakeholders (Customer Service, Supply Planning, Quality, Regulatory, Artwork & Label Operations) on order book management, product/licence withdrawals, and ensuring uninterrupted supply

Responsibilities

  • Quality evaluation of Purchase Orders in compliance with Distribution Agreements
  • System Price Maintenance
  • Maintain rolling commercial forecasts in collaboration with distributors & Commercial Lead
  • Minimise forecast variance
  • On-boarding of new distribution partners
  • System setup of new client ship to location
  • Manage NPI within GPS regions
  • Collaborate with Key stakeholders on product/licence withdrawals
  • Manage open order book

Skills

Trade Operations
Supply Chain Management
International Trade
Regulatory Compliance
Patient Access
Global Health Logistics

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI